Celltrion Q2 Operating Income Jumps
(RTTNews) - Celltrion, Inc. (068270.KS), a biopharmaceutical company, on Friday reported higher operating income and sales in the second quarter of 2026 compared with the same period last year.
For the second quarter, operating income also jumped to KRW 751.9 billion from KRW 391.9 billion
Sales for the period increased to KRW 2.45 trillion from KRW 1.80 trillion in the previous year.
Celltrion closed trading 3.96% higher at KRW 183,600 on the Korean Stock Exchange.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.